IgG+ Extracellular Vesicles Measure Therapeutic Response in Advanced Pancreatic Cancer

(1) Background: Pancreatic ductal adenocarcinoma (PDAC) is expected to be the second-leading cause of cancer deaths by 2030. Imaging techniques are the standard for monitoring the therapy response in PDAC, but these techniques have considerable limits, including delayed disease progression detection...

ver descrição completa

Detalhes bibliográficos
Autor principal: Couto, Nuno (author)
Outros Autores: Elzanowska, Julia (author), Maia, Joana (author), Batista, Silvia (author), Pereira, Catarina Esteves (author), Beck, Hans Christian (author), Carvalho, Ana Sofia (author), Moraes, Maria Carolina Strano (author), Carvalho, Carlos (author), Oliveira, Manuela (author), Matthiesen, Rune (author), Costa-Silva, Bruno (author)
Formato: article
Idioma:eng
Publicado em: 2022
Assuntos:
pancreatic cancer
extracellular vesicles
liquid biopsy
biomaker
IgG
Texto completo:http://hdl.handle.net/10174/33049
http://hdl.handle.net/10174/33049
País:Portugal
Oai:oai:dspace.uevora.pt:10174/33049

Texto Completo

http://hdl.handle.net/10174/33049
http://hdl.handle.net/10174/33049

Registos relacionados